LPCN
Price
$3.35
Change
+$0.17 (+5.35%)
Updated
Apr 1, 04:46 PM (EDT)
Capitalization
16.85M
TARA
Price
$4.01
Change
-$0.25 (-5.87%)
Updated
Apr 1 closing price
Capitalization
147.44M
29 days until earnings call
Ad is loading...

LPCN vs TARA

Header iconLPCN vs TARA Comparison
Open Charts LPCN vs TARABanner chart's image
Lipocine
Price$3.35
Change+$0.17 (+5.35%)
Volume$122
Capitalization16.85M
Protara Therapeutics
Price$4.01
Change-$0.25 (-5.87%)
Volume$260.13K
Capitalization147.44M
LPCN vs TARA Comparison Chart
Loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPCN vs. TARA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a StrongBuy and TARA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (LPCN: $3.18 vs. TARA: $4.26)
Brand notoriety: LPCN and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 42% vs. TARA: 143%
Market capitalization -- LPCN: $16.85M vs. TARA: $147.44M
LPCN [@Biotechnology] is valued at $16.85M. TARA’s [@Biotechnology] market capitalization is $147.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than LPCN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 4 bullish TA indicator(s).

  • LPCN’s TA Score: 4 bullish, 4 bearish.
  • TARA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LPCN is a better buy in the short-term than TARA.

Price Growth

LPCN (@Biotechnology) experienced а -13.59% price change this week, while TARA (@Biotechnology) price change was -9.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

LPCN is expected to report earnings on Aug 09, 2023.

TARA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($147M) has a higher market cap than LPCN($16.9M). TARA YTD gains are higher at: -19.318 vs. LPCN (-34.836). LPCN has higher annual earnings (EBITDA): -3.68M vs. TARA (-48.82M). TARA has more cash in the bank: 170M vs. LPCN (19.8M). LPCN has less debt than TARA: LPCN (1.48M) vs TARA (4.48M). LPCN has higher revenues than TARA: LPCN (7.92M) vs TARA (0).
LPCNTARALPCN / TARA
Capitalization16.9M147M11%
EBITDA-3.68M-48.82M8%
Gain YTD-34.836-19.318180%
P/E RatioN/AN/A-
Revenue7.92M0-
Total Cash19.8M170M12%
Total Debt1.48M4.48M33%
FUNDAMENTALS RATINGS
LPCN vs TARA: Fundamental Ratings
LPCN
TARA
OUTLOOK RATING
1..100
782
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
6436
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (22) in the null industry is in the same range as LPCN (42) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as LPCN (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

LPCN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as TARA (97) in the null industry. This means that LPCN’s stock grew similarly to TARA’s over the last 12 months.

TARA's Price Growth Rating (36) in the null industry is in the same range as LPCN (64) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

LPCN's P/E Growth Rating (96) in the Pharmaceuticals Other industry is in the same range as TARA (100) in the null industry. This means that LPCN’s stock grew similarly to TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPCNTARA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBR67.690.68
+1.01%
Sabine Royalty Trust
NMG1.51N/A
N/A
Nouveau Monde Graphite
HUBB330.91-1.10
-0.33%
Hubbell
SKYW87.37-1.39
-1.57%
SkyWest
BOLT0.40-0.03
-5.88%
Bolt Biotherapeutics

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-3.05%
SPRY - LPCN
63%
Loosely correlated
+0.72%
IPA - LPCN
43%
Loosely correlated
-3.95%
ZNTL - LPCN
37%
Loosely correlated
-12.15%
TARA - LPCN
30%
Poorly correlated
-6.99%
CRSP - LPCN
27%
Poorly correlated
-8.00%
More